Published online before print January 22, 2008, doi: 10.1161/CIRCULATIONAHA.107.699579
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:743-753.)
© 2008 American Heart Association, Inc.
Epidemiology |
General Cardiovascular Risk Profile for Use in Primary Care
The Framingham Heart Study
From Boston University, Department of Mathematics and Statistics (R.B.D., M.J.P.), School of Medicine (R.S.V., P.A.W., W.B.K.), and Department of Biostatistics (J.M.M.), Boston, Mass; Framingham Heart Study, Framingham, Mass (R.B.D., R.S.V., M.J.P., P.A.W., J.M.M., W.B.K.); and Unilever Research, Corporate Biology, Colworth Park, UK (M.C.).
Correspondence to R.B. D’Agostino, PhD, Chairman, Professor of Mathematics/Statistics and Public Health, Boston University, Department of Mathematics and Statistics, 111 Cummington St, Boston, MA 02215.
Received February 27, 2007; accepted November 30, 2007.
Background— Separate multivariable risk algorithms are commonly used to assess risk of specific atherosclerotic cardiovascular disease (CVD) events, ie, coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure. The present report presents a single multivariable risk function that predicts risk of developing all CVD and of its constituents.
Methods and Results— We used Cox proportional-hazards regression to evaluate the risk of developing a first CVD event in 8491 Framingham study participants (mean age, 49 years; 4522 women) who attended a routine examination between 30 and 74 years of age and were free of CVD. Sex-specific multivariable risk functions ("general CVD" algorithms) were derived that incorporated age, total and high-density lipoprotein cholesterol, systolic blood pressure, treatment for hypertension, smoking, and diabetes status. We assessed the performance of the general CVD algorithms for predicting individual CVD events (coronary heart disease, stroke, peripheral artery disease, or heart failure). Over 12 years of follow-up, 1174 participants (456 women) developed a first CVD event. All traditional risk factors evaluated predicted CVD risk (multivariable-adjusted P<0.0001). The general CVD algorithm demonstrated good discrimination (C statistic, 0.763 [men] and 0.793 [women]) and calibration. Simple adjustments to the general CVD risk algorithms allowed estimation of the risks of each CVD component. Two simple risk scores are presented, 1 based on all traditional risk factors and the other based on non–laboratory-based predictors.
Conclusions— A sex-specific multivariable risk factor algorithm can be conveniently used to assess general CVD risk and risk of individual CVD events (coronary, cerebrovascular, and peripheral arterial disease and heart failure). The estimated absolute CVD event rates can be used to quantify risk and to guide preventive care.
CLINICAL PERSPECTIVE
Related Article:
-
Clinical Summaries
Circulation 2008 117: 711-713.[Extract] [Full Text]
This article has been cited by other articles:
 |
|
 |
|
  Chia Yook Chin and S. Pengal Cardiovascular Disease Risk in a Semirural Community in Malaysia Asia Pac J Public Health, October 1, 2009; 21(4): 410 - 420. [Abstract] [PDF]
|
|
|
|
 |
|
 M. T. Cooney, A. L. Dudina, and I. M. Graham Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1209 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, S. Mora, et al. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1364 - 1405. [Full Text] [PDF]
|
|
|
|
 |
|
 WRITING COMMITTEE MEMBERS, R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, et al. ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research Circulation, September 29, 2009; 120(13): 1296 - 1336. [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Cook and M. A. Albert Regarding REGARDS: Does Inflammation Explain Racial and Regional Differences in Cardiovascular Disease Risk? Clin. Chem., September 1, 2009; 55(9): 1603 - 1605. [Full Text] [PDF]
|
|
|
|
|
|
M. Cushman, L. A. McClure, V. J. Howard, N. S. Jenny, S. G. Lakoski, and G. Howard Implications of Increased C-Reactive Protein for Cardiovascular Risk Stratification in Black and White Men and Women in the US Clin. Chem., September 1, 2009; 55(9): 1627 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Marma and D. M. Lloyd-Jones Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile Circulation, August 4, 2009; 120(5): 384 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Vasan and W. B. Kannel Strategies for Cardiovascular Risk Assessment and Prevention Over the Life Course: Progress Amid Imperfections Circulation, August 4, 2009; 120(5): 360 - 363. [Full Text] [PDF]
|
|
|
|
 |
|
 G. S Collins and D. G Altman An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study BMJ, July 7, 2009; 339(jul07_2): b2584 - b2584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Jackson, R. Marshall, A. Kerr, T. Riddell, and S. Wells QRISK or Framingham for predicting cardiovascular risk? BMJ, July 7, 2009; 339(jul07_2): b2673 - b2673. [Full Text]
|
|
|
|
 |
|
 A. S. Leon and U. G. Bronas Dyslipidemia and Risk of Coronary Heart Disease: Role of Lifestyle Approaches for Its Management American Journal of Lifestyle Medicine, July 1, 2009; 3(4): 257 - 273. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Pencina, R. B. D'Agostino Sr, M. G. Larson, J. M. Massaro, and R. S. Vasan Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study Circulation, June 23, 2009; 119(24): 3078 - 3084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Hlatky and P. A. Heidenreich The Year in Epidemiology, Health Services Research, and Outcomes Research J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1459 - 1466. [Full Text] [PDF]
|
|
|
|
|
|
J. Sanz, P. R. Moreno, and V. Fuster The year in atherothrombosis. J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1326 - 1337. [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Simmons, R. L. Coleman, H. C. Price, R. R. Holman, K.-T. Khaw, N. J. Wareham, and S. J. Griffin Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort Diabetes Care, April 1, 2009; 32(4): 708 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zhang, F. Rao, B. K. Rana, J. R. Gayen, F. Calegari, A. King, P. Rosa, W. B. Huttner, M. Stridsberg, M. Mahata, et al. Autonomic Function in Hypertension: Role of Genetic Variation at the Catecholamine Storage Vesicle Protein Chromogranin B Circ Cardiovasc Genet, February 1, 2009; 2(1): 46 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
WRITING GROUP MEMBERS, D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 27, 2009; 119(3): e21 - e181. [Full Text] [PDF]
|
|
|
|
|
|
I. A Scott Evaluating cardiovascular risk assessment for asymptomatic people BMJ, January 5, 2009; 338(jan05_1): a2844 - a2844. [Full Text]
|
|
|
|
 |
|
 J. Cui, N. de Klerk, M. Abramson, A. Del Monaco, G. Benke, M. Dennekamp, A. W. Musk, and M. Sim Fractional Polynomials and Model Selection in Generalized Estimating Equations Analysis, With an Application to a Longitudinal Epidemiologic Study in Australia Am. J. Epidemiol., January 1, 2009; 169(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B. Kannel and P. A. Wolf Framingham Study Insights on the Hazards of Elevated Blood Pressure JAMA, December 3, 2008; 300(21): 2545 - 2547. [Full Text] [PDF]
|
|
|
|
|
|
P. M Ridker, N. P. Paynter, N. Rifai, J. M. Gaziano, and N. R. Cook C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men Circulation, November 25, 2008; 118(22): 2243 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Donner-Banzhoff and A. Sonnichsen Statins and primary prevention of cardiovascular events BMJ, November 14, 2008; 337(nov14_2): a2576 - a2576. [Full Text]
|
|
|
|
 |
|
 P. W.F. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino Sr, and C. J. O'Donnell C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. O'Donnell and E. G. Nabel Cardiovascular Genomics, Personalized Medicine, and the National Heart, Lung, and Blood Institute: Part I: The Beginning of an Era Circ Cardiovasc Genet, October 1, 2008; 1(1): 51 - 57. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Yeh, S. Rahangdale, and A. Malhotra Metabolic Syndrome, Obstructive Sleep Apnea, and Continuous Positive Airway Pressure: A Weighty Issue Chest, October 1, 2008; 134(4): 675 - 676. [Full Text] [PDF]
|
|
|
|
|
|
Z. Dorkova, D. Petrasova, A. Molcanyiova, M. Popovnakova, and R. Tkacova Effects of Continuous Positive Airway Pressure on Cardiovascular Risk Profile in Patients With Severe Obstructive Sleep Apnea and Metabolic Syndrome Chest, October 1, 2008; 134(4): 686 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cederholm, K. Eeg-Olofsson, B. Eliasson, B. Zethelius, P. M. Nilsson, S. Gudbjornsdottir, and on behalf of the Swedish National Diabetes Registe Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register Diabetes Care, October 1, 2008; 31(10): 2038 - 2043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.F. Wilson, S. R. Bozeman, T. M. Burton, D. C. Hoaglin, R. Ben-Joseph, and C. L. Pashos Prediction of First Events of Coronary Heart Disease and Stroke With Consideration of Adiposity Circulation, July 8, 2008; 118(2): 124 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hippisley-Cox, C. Coupland, Y. Vinogradova, J. Robson, R. Minhas, A. Sheikh, and P. Brindle Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 BMJ, June 28, 2008; 336(7659): 1475 - 1482. [Abstract] [Full Text] [PDF]
|
|